ScholarIQanswers from OpenAlex

Postvaccination antibody titres predict protection against COVID-19 in patients with autoimmune diseases: survival analysis in a prospective cohort

PaperCitations, authors & open-access status

Postvaccination antibody titres predict protection against COVID-19 in patients with autoimmune diseases: survival analysis in a prospective cohort is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Postvaccination antibody titres predict protection against COVID-19 in patients with autoimmune diseases: survival analysis in a prospective cohort have?

ScholarIQcitation count

Postvaccination antibody titres predict protection against COVID-19 in patients with autoimmune diseases: survival analysis in a prospective cohort has 76 citations in the OpenAlex counts ScholarIQ stores.

When was Postvaccination antibody titres predict protection against COVID-19 in patients with autoimmune diseases: survival analysis in a prospective cohort published?

ScholarIQyear

Postvaccination antibody titres predict protection against COVID-19 in patients with autoimmune diseases: survival analysis in a prospective cohort has 2022 year in the ScholarIQ index.

What is the open-access status of Postvaccination antibody titres predict protection against COVID-19 in patients with autoimmune diseases: survival analysis in a prospective cohort?

ScholarIQoa status

Postvaccination antibody titres predict protection against COVID-19 in patients with autoimmune diseases: survival analysis in a prospective cohort has closed oa status in the ScholarIQ index.

What is the DOI of Postvaccination antibody titres predict protection against COVID-19 in patients with autoimmune diseases: survival analysis in a prospective cohort?

ScholarIQdoi

The DOI for Postvaccination antibody titres predict protection against COVID-19 in patients with autoimmune diseases: survival analysis in a prospective cohort is on the source record.

What is the PMID of Postvaccination antibody titres predict protection against COVID-19 in patients with autoimmune diseases: survival analysis in a prospective cohort?

ScholarIQpmid

The PMID for Postvaccination antibody titres predict protection against COVID-19 in patients with autoimmune diseases: survival analysis in a prospective cohort is on the source record.

What is the OpenAlex record for Postvaccination antibody titres predict protection against COVID-19 in patients with autoimmune diseases: survival analysis in a prospective cohort?

ScholarIQopenalex

The OpenAlex for Postvaccination antibody titres predict protection against COVID-19 in patients with autoimmune diseases: survival analysis in a prospective cohort is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial